{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:01:34Z","timestamp":1789038094273,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jacc.2019.06.030","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T15:38:43Z","timestamp":1565019523000},"page":"774-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Homeostatic Chemokines and Prognosis\u00a0in Patients With Acute Coronary Syndromes"],"prefix":"10.1016","volume":"74","author":[{"given":"Kenneth","family":"Caidahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Hartford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annica","family":"Ravn-Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Lorentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Yndestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2019.06.030_bib1","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jama.2009.1178","article-title":"Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006","volume":"302","author":"Krumholz","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2019.06.030_bib2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/eurheartj\/ehu505","article-title":"Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective","volume":"36","author":"Jernberg","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2019.06.030_bib3","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1373\/clinchem.2004.046292","article-title":"Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome","volume":"51","author":"Apple","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacc.2019.06.030_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007947","article-title":"Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores","volume":"4","author":"Aragam","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2019.06.030_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCRESAHA.118.311098","article-title":"Reassessing the mechanisms of acute coronary syndromes","volume":"124","author":"Libby","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2019.06.030_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"Forster","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jacc.2019.06.030_bib7","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/eji.200737201","article-title":"Distinctive role of CCR7 in migration and functional activity of naive- and effector\/memory-like Treg subsets","volume":"37","author":"Menning","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jacc.2019.06.030_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1084\/jem.20061405","article-title":"CCR7 is required for the in\u00a0vivo function of CD4+ CD25+ regulatory T cells","volume":"204","author":"Schneider","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jacc.2019.06.030_bib9","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/ATVBAHA.113.303081","article-title":"Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease","volume":"34","author":"Cai","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2019.06.030_bib10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.ATV.0000255581.38523.7c","article-title":"Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization","volume":"27","author":"Damas","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2019.06.030_bib11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/cvr\/cvu036","article-title":"Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells","volume":"102","author":"Halvorsen","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2019.06.030_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/cvr\/cvs349","article-title":"Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice","volume":"97","author":"Wan","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jacc.2019.06.030_bib13","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1161\/CIRCULATIONAHA.110.956730","article-title":"Chemokine receptor 7 knockout attenuates atherosclerotic plaque development","volume":"122","author":"Luchtefeld","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.06.030_bib14","article-title":"CCR7-CCL19\/CCL21 axis is essential for effective arteriogenesis in a murine model of hindlimb ischemia","volume":"6","author":"Nossent","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2019.06.030_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112172","article-title":"The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodeling","volume":"9","author":"Finsen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2019.06.030_bib16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/eurjhf\/hft031","article-title":"CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials","volume":"15","author":"Ueland","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2019.06.030_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033038","article-title":"The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure","volume":"7","author":"Yndestad","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2019.06.030_bib18","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1161\/01.CIR.0000041661.63285.AE","article-title":"N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes","volume":"106","author":"Omland","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2019.06.030_bib19","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jacc.2019.06.030_bib20","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2147\/DDDT.S72394","article-title":"CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions","volume":"8","author":"Akhavanpoor","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jacc.2019.06.030_bib21","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1159\/000430224","article-title":"Anti-CCL21 antibody attenuates infarct size and improves cardiac remodeling after myocardial infarction","volume":"37","author":"Jiang","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jacc.2019.06.030_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11239-010-0471-7","article-title":"Inflammatory response to percutaneous coronary intervention in stable coronary artery disease","volume":"31","author":"Munk","year":"2011","journal-title":"J\u00a0Thromb Thrombolysis"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719356852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109719356852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:22:54Z","timestamp":1760016174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109719356852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0735109719356852"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2019.06.030","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homeostatic Chemokines and Prognosis\u00a0in Patients With Acute Coronary Syndromes","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2019.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}